MedTrace Logo

Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease

NCT06790147 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-05-16

No results posted yet for this study

Summary

The goal of this observational study is to establish a prospective multicenter registry of patients undergoing intracranial stenting for ischemic strokes caused by medically refractory ICAD. The study aims to evaluate current practice patterns, periprocedural outcomes, and delayed outcomes.

Researchers will collect demographic and procedural data from patients who undergo intracranial stenting after having an ischemic stroke caused by medically refractory ICAD.

Conditions

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Nitin Goyal

    lead OTHER

Principal Investigators

  • Nitin Goyal, MD · Semmes Murphey Clinic

  • Violiza Inoa, MD · Semmes Murphey Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2027-08-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06790147 on ClinicalTrials.gov